Linden Thomas Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $961K | Buy |
|
|||||
|
2025
Q2 | $842K | Buy |
|
|||||
|
2025
Q1 | $730K | Buy |
|
|||||
|
2024
Q4 | $867K | Buy |
|
|||||
|
2024
Q3 | $698K | Buy |
|
|||||
|
2024
Q2 | $798K | Sell |
|
|||||
|
2024
Q1 | $933K | Buy |
|
|||||
|
2023
Q4 | $851K | Buy |
|
|||||
|
2023
Q3 | $701K | Sell |
|
|||||
|
2023
Q2 | $1.46M | Buy |
|
|||||
|
2023
Q1 | $1.56M | Buy |
|
|||||
|
2022
Q4 | $1.79M | Buy |
|